The Measles-Containing-Vaccine Second-Dose (MCV2) immunization coverage in Canada is forecasted to decline steadily from 76% in 2024 to 72% in 2028. This reflects a year-on-year decrease of approximately 1.32%. In 2023, actual data indicated the rate was slightly higher, highlighting a weakening trend in achieving full immunization coverage among children of the nationally recommended age. The compounded annual growth rate (CAGR) over the five-year forecast is a negative value, suggesting a declining trend in immunization rates.
Future trends to watch for include potential policy changes or public health campaigns aimed at reversing the decline in MCV2 coverage, as well as societal factors affecting vaccine uptake such as vaccine hesitancy and accessibility issues. Additionally, monitoring innovations in vaccine distribution and education might offset this downward trend.
